Should patients with ovarian cancer receive intraperitoneal chemotherapy following initial cytoreductive surgery?

被引：0
|
作者：
Carolyn Runowicz
机构：
[1] Director of the Neag Comprehensive Cancer Center at the University of Connecticut Health Center,
来源：
Nature Clinical Practice Oncology | 2006年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：416 / 417
页数：1
相关论文
共 50 条
  • [1] Should patients with ovarian cancer receive intraperitoneal chemotherapy following initial cytoreductive surgery?
    Runowicz, Carolyn
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (08): : 416 - 417
  • [2] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in ovarian cancer
    Schmalfeldt, Barbara
    CHIRURGIE, 2022, 93 (12): : 1144 - 1151
  • [3] Cytoreductive surgery following neoadjuvant chemotherapy in patients with initial unresectable stage IV ovarian cancer
    Hogen, Liat
    Tanen, Adina
    May, Taymaa
    Avery, Lisa
    Ferguson, Sarah
    Laframboise, Stephane
    Bouchard-Fortier, Genevieve
    Bernardini, Marcus
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S132 - S132
  • [4] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for treatment of ovarian cancer
    Polom, Karol
    Roviello, Giandomenico
    Generali, Daniele
    Marano, Luigi
    Petrioli, Roberto
    Marsili, Stefania
    Caputo, Edda
    Marrelli, Daniele
    Roviello, Franco
    INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2016, 32 (03) : 298 - 310
  • [5] Cytoreductive surgery and perioperative intraperitoneal chemotherapy in recurrent ovarian cancer
    Tentes, Antonios-Apostolos K.
    Korakianitis, Odysseas S.
    Kakolyris, Stylianos
    Kyziridis, Dimitrios
    Veliovits, Dousan
    Karagiozoglou, Chrysa
    Sgouridou, Evanthia
    Moustakas, Konstantinos
    TUMORI, 2010, 96 (03) : 411 - 416
  • [6] Feasibility and pharmacokinetics of intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) with paclitaxel following cytoreductive surgery in ovarian cancer patients
    De Bree, E.
    Rosing, H.
    Filis, D.
    Romanos, J.
    Melissourgaki, M.
    Daskalakis, M.
    Pilatou, M.
    Sanidas, E.
    Beijnen, J. H.
    Tsiftsis, D. D.
    EJC SUPPLEMENTS, 2007, 5 (04): : 320 - 321
  • [7] Neoadjuvant chemotherapy/cytoreductive surgery/intraperitoneal chemotherapy for ovarian cancer: A feasibility assessment
    Scamon, L. G.
    Richard, S. D.
    Mcbee, W. C.
    Lesnock, J. L.
    Hurt, J. D.
    O'Malley, D. M.
    Krivak, T. C.
    GYNECOLOGIC ONCOLOGY, 2009, 112 (02) : S143 - S143
  • [8] Splenectomy in Cytoreductive Surgery for Advanced Ovarian Cancer and Subsequent Intraperitoneal Chemotherapy
    Pant, Alok C.
    Santillan, Antonio
    Diaz-Montes, Teresa
    Giuntoli, Robert L.
    Bristow, Robert E.
    JOURNAL OF GYNECOLOGIC SURGERY, 2010, 26 (03) : 179 - 182
  • [9] Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for ovarian cancer: opportunity and obligations
    Miner, Thomas J.
    13TH WORLD CONGRESS ON CONTROVERSIES IN OBSTETRICS, GYNECOLOGY & INFERTILITY (COGI) HELD JOINTLY WITH THE GERMAN SOCIETY OF OBSTETRICS & GYNECOLOGY, 2010, : 37 - 39
  • [10] Hyperthermic intraperitoneal chemotherapy with and without cytoreductive surgery for epithelial ovarian cancer
    Helm, C. William
    Bristow, Robert E.
    Kusamura, Shigeki
    Baratti, Dario
    Deraco, Marcello
    JOURNAL OF SURGICAL ONCOLOGY, 2008, 98 (04) : 283 - 290
12345